Baron Silver Stevens Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Baron Silver Stevens Financial Advisors's BMY Position: Q4 2023 in Review
Baron Silver Stevens Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,603 shares — an estimated $209K sold.
Baron Silver Stevens Financial Advisors first reported a position in BMY in Q4 2020 and held it in 11 quarters. The position peaked at $333K in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Baron Silver Stevens Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- Baron Silver Stevens Financial Advisors sold 3,603 Bristol-Myers Squibb shares in Q4 2023, an estimated $209K.
- Baron Silver Stevens Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 11 quarters.
- Baron Silver Stevens Financial Advisors's Bristol-Myers Squibb position peaked at $333K in Q2 2022.
- 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Baron Silver Stevens Financial Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.